You are here
March 31, 2015
How Vitamin D May Affect Heart Disease, Diabetes
At a Glance
- Mice with immune cells unable to use vitamin D developed atherosclerosis and insulin resistance, precursors of heart disease and type 2 diabetes.
- The mechanisms uncovered may lead to novel therapies. The findings also suggest that vitamin D might help prevent the complications of diabetes and inflammation.
Vitamin D deficiency has been linked to heart disease and type 2 diabetes. Chronic inflammation plays a role in both of these diseases, and most immune cells have receptors for vitamin D. Binding of vitamin D to its receptor regulates many key processes inside cells. However, the mechanisms connecting activation of the immune system with these diseases aren’t well understood.
Heart disease stems from atherosclerosis, which occurs when a substance called plaque builds up inside blood vessels. Plaque consists of fat, cholesterol, calcium, and other materials found in the blood. Over time, the buildup can cause hardening and narrowing of arteries and can lead to coronary heart disease, heart attack, and stroke.
Type 2 diabetes usually begins with insulin resistance, a condition in which the body produces insulin but isn’t able to use it effectively. As a result, glucose builds up in blood and may ultimately damage nerves, blood vessels, and other body parts.
A team of researchers led by Dr. Carlos Bernal-Mizrachi at Washington University School of Medicine set out to examine the connections among vitamin D, immune function, atherosclerosis, and insulin resistance. They genetically altered mice to lack vitamin D receptors in 2 types of inflammation-related immune cells: monocytes and macrophages. Without these receptors, the cells couldn’t respond to vitamin D. The study was supported in part by NIH’s National Heart, Lung, and Blood Institute (NHLBI). Results appeared on March 24, 2015, in Cell Reports.
Both types of mice developed insulin resistance. Macrophages accumulated in the liver, which made excess glucose. The engineered mice also developed atherosclerosis that was spurred by monocytes lacking vitamin D receptors. The monocytes became filled with cholesterol and carried the cholesterol to plaques. This process of atherosclerosis is different from that involving LDL cholesterol.
When the researchers added normal immune cells back into the engineered mice, their insulin sensitivity improved and atherosclerosis declined. This finding showed that vitamin D pathways in immune cells play a key role in chronic inflammation that, in turn, affects development of insulin resistance and atherosclerosis.
“Inactivation of the vitamin D receptor induced diabetes and atherosclerosis, so normalizing vitamin D levels may have the opposite effect,” Bernal-Mizrachi says. “The identification of monocyte cholesterol transport as a mechanism for atherosclerosis in our animal model opens up a new area of research that could identify novel therapies for heart disease.”
The group is now conducting clinical trials in people with type 2 diabetes to see whether vitamin D treatment can prevent some of the complications of diabetes and inflammation.
—by Carol Torgan, Ph.D.
- Immune System Shaped by Environment More Than Genes
- Immune Cells in Heart Help it Mend
- Vitamin D Levels Predict Multiple Sclerosis Progression
- Insulin Resistance and Prediabetes
- Vitamin D
Reference: Deletion of Macrophage Vitamin D Receptor Promotes Insulin Resistance and Monocyte Cholesterol Transport to Accelerate Atherosclerosis in Mice. Oh J, Riek AE, Darwech I, Funai K, Shao J, Chin K, Sierra OL, Carmeliet G, Ostlund RE Jr, Bernal-Mizrachi C. Cell Rep. 2015 Mar 17. pii: S2211-1247(15)00201-6. doi: 10.1016/j.celrep.2015.02.043. [Epub ahead of print]. PMID: 25801026.
Funding: NIH’s National Heart, Lung, and Blood Institute (NHLBI), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Advancing Translational Sciences (NCATS), and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children’s Discovery Institute; American Diabetes Association; and Washington University.